RecruitingNot ApplicableNCT05579470

Expanding Medication-Assisted Therapies in Central Asia


Sponsor

Yale University

Enrollment

900 participants

Start Date

Aug 7, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

Central Asia (CA) represents the most rapidly growing HIV epidemic region worldwide, concentrated in people who inject drugs (PWID) and their sexual partners, and scaling up opioid agonist therapies (OAT) in this region is the most cost-effective strategy to prevent new HIV infections, and more effective when combined with antiretroviral therapy (ART). The investigators propose to use the Network for the Improvement of Addiction Treatment (NIATx) implementation strategy to scale-up OAT in three diverse Central Asian countries (Kazakhstan, Kyrgyzstan, Tajikistan) and guided by the Exploration-Planning-Implementation-Sustainment (EPIS) framework. Understanding the trajectories of implementation and scale-up in this context may emerge through creating communities of practice, especially when cohesion and competence evolves, and may guide other healthcare delivery challenges in the region (e.g., HIV, TB); as well as build important regional expertise and understanding implementation trajectories should help support OAT program sustainability.


Eligibility

Min Age: 18 Years

Inclusion Criteria22

  • Quantitative surveys for PWID
  • years or older
  • Meeting DSM-V criteria for opioid dependence
  • Be either treatment naïve and seeking OAT or be on OAT for \< 90 days
  • Organizational Assessments for OAT Delivery Staff
  • years or older
  • Currently working as an OAT delivery professional at an OAT delivery site
  • Focus Groups (PWID on OAT)
  • years or older
  • Meeting DSM-V criteria for opioid dependence
  • Be either treatment naïve and seeking OAT or be on OAT for \< 90 days
  • Focus Groups (PWID not on OAT)
  • years or older
  • Meeting Diagnostic and Statistical Manual of Mental Disorders(DSM)-V criteria for opioid dependence
  • Be OAT naïve (defined as never having been on OAT or having not received treatment for \> 1 year)
  • Focus Groups (OAT delivery staff)
  • years or older
  • Currently working as an OAT delivery professional at an OAT delivery site
  • years or older
  • Currently assigned as a Chief Narcologist for an Oblast
  • years or older
  • Authorized as a professional to work at an OAT delivery site

Exclusion Criteria1

  • Not willing to provide consent

Interventions

BEHAVIORALNIATx

For each country, the learning collaborative will be comprised of a Chief Narcologist from each region where the investigators will initially train them and the coaches using all the tools from the NIATx Academy (2-3-day training). The national coach for each country will receive ongoing and in-depth coaching from a US-based super coach. A nationwide Nominal Group Technique (NGT) will be conducted to assess barriers and potential targets to guide decision-making about changes. At the end of the initial meeting, each Chief Narcologist (CN) will be able to identify a change target for Plan, Do, Study, Act (PDSA) (entry, retention) and create a Change Project Form to state what will be done (e.g. flowcharting), who is involved (team), what are the measures and timeframe (\<4 weeks).


Locations(4)

Yale University

New Haven, Connecticut, United States

Columbia University Global Health Research Center of Central Asia

Almaty, Kazakhstan

Den Sooluk Nuru

Bishkek, Kyrgyzstan

Institute for International Health and Education

Dushanbe, Tajikistan

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05579470


Related Trials